MX378251B - Uso de agonistas del receptor nicotinico de acetilcolina alfa 7. - Google Patents

Uso de agonistas del receptor nicotinico de acetilcolina alfa 7.

Info

Publication number
MX378251B
MX378251B MX2015009155A MX2015009155A MX378251B MX 378251 B MX378251 B MX 378251B MX 2015009155 A MX2015009155 A MX 2015009155A MX 2015009155 A MX2015009155 A MX 2015009155A MX 378251 B MX378251 B MX 378251B
Authority
MX
Mexico
Prior art keywords
alpha
acetylcholine receptor
nicotinic acetylcholine
receptor agonists
facilitation
Prior art date
Application number
MX2015009155A
Other languages
English (en)
Other versions
MX2015009155A (es
Inventor
Markus Fendt
Dominik Feuerbach
Christer Halldin
Donald Johns
FINNEMA Johannes SJOERD
Cristina Lopez-Lopez
Kevin Hall Mcallister
Judit Sovago
Markus Weiss
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2015009155A publication Critical patent/MX2015009155A/es
Publication of MX378251B publication Critical patent/MX378251B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se refiere al uso de cierto agonista del receptor nicotínico de acetilcolina alfa 7 para facilitar la recuperación de la anestesia general.
MX2015009155A 2013-01-15 2014-01-13 Uso de agonistas del receptor nicotinico de acetilcolina alfa 7. MX378251B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361752772P 2013-01-15 2013-01-15
PCT/IB2014/058225 WO2014111838A1 (en) 2013-01-15 2014-01-13 Use of alpha 7 nicotinic acetylcholine receptor agonists

Publications (2)

Publication Number Publication Date
MX2015009155A MX2015009155A (es) 2016-03-04
MX378251B true MX378251B (es) 2025-03-10

Family

ID=50070639

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015009155A MX378251B (es) 2013-01-15 2014-01-13 Uso de agonistas del receptor nicotinico de acetilcolina alfa 7.

Country Status (10)

Country Link
EP (1) EP2945633B1 (es)
JP (1) JP6338223B2 (es)
KR (1) KR101879920B1 (es)
CN (1) CN105263495B (es)
BR (1) BR112015016995B8 (es)
CA (1) CA2898080C (es)
ES (1) ES2883232T3 (es)
MX (1) MX378251B (es)
TW (1) TWI633886B (es)
WO (1) WO2014111838A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020001425A (es) 2017-08-04 2020-08-06 Skyhawk Therapeutics Inc Metodos y composiciones para modular el empalme.
EP3713574A4 (en) * 2017-11-22 2021-08-04 The Governors of the University of Alberta PROCESS FOR CONTROLLING RESPIRATORY DEPRESSION BY ACTIVATION OF NICOTINIC NEURAL ACETYLCHOLINE RECEPTORS HETEROMERIC
WO2020163248A1 (en) 2019-02-04 2020-08-13 Skyhawk Therapeutics, Inc. Methods and compositions for modulating splicing
WO2020163541A1 (en) 2019-02-05 2020-08-13 Skyhawk Therapeutics, Inc. Methods and compositions for modulating splicing
KR102913697B1 (ko) 2019-02-05 2026-01-15 스카이호크 테라퓨틱스, 인코포레이티드 스플라이싱을 조절하는 방법 및 조성물
KR102925385B1 (ko) 2019-02-06 2026-02-11 스카이호크 테라퓨틱스, 인코포레이티드 스플라이싱을 조절하는 방법 및 조성물
JP7603594B2 (ja) 2019-02-06 2024-12-20 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
CN115192558B (zh) * 2021-04-02 2023-12-29 四川大学华西医院 一种环状酮类化合物的用途

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6953855B2 (en) 1998-12-11 2005-10-11 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
GB0010955D0 (en) 2000-05-05 2000-06-28 Novartis Ag Organic compounds
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
GB0220581D0 (en) * 2002-09-04 2002-10-09 Novartis Ag Organic Compound
CA2499128C (en) 2002-09-25 2012-07-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
WO2006065233A1 (en) 2004-12-10 2006-06-22 Abbott Laboratories Fused bicycloheterocycle substituted quinuclidine derivatives
US20050245531A1 (en) 2003-12-22 2005-11-03 Abbott Laboratories Fused bicycloheterocycle substituted quinuclidine derivatives
GB0412019D0 (en) 2004-05-28 2004-06-30 Novartis Ag Organic compounds
PE20060437A1 (es) 2004-06-18 2006-06-08 Novartis Ag COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR
GB0415746D0 (en) * 2004-07-14 2004-08-18 Novartis Ag Organic compounds
GB0521508D0 (en) 2005-10-21 2005-11-30 Novartis Ag Organic compounds
GB0525672D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
GB0525673D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
TW200813067A (en) 2006-05-17 2008-03-16 Astrazeneca Ab Nicotinic acetylcholine receptor ligands
NZ573735A (en) 2006-05-19 2011-10-28 Abbott Lab Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives
US8314119B2 (en) 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
CN100448468C (zh) * 2006-11-14 2009-01-07 赵玉民 一种口服用于治疗胃病的药粉
SA08290475B1 (ar) 2007-08-02 2013-06-22 Targacept Inc (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
WO2009066107A1 (en) 2007-11-21 2009-05-28 Astrazeneca Ab Use of a nicotinic receptor agonist
WO2010043515A1 (en) 2008-10-13 2010-04-22 F. Hoffmann-La Roche Ag Diazonium-free method to make an indazole intermediate in the synthesis of bicyclic 5-(trifluormethoxy)-1h-3-indazolecarboxylic acid amides
CN102209540A (zh) * 2008-11-11 2011-10-05 塔加西普特公司 使用α7-选择性配体的治疗方法
TW201031664A (en) 2009-01-26 2010-09-01 Targacept Inc Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
TWI558398B (zh) * 2009-09-22 2016-11-21 諾華公司 菸鹼乙醯膽鹼受體α7活化劑之用途
HRP20150560T2 (hr) * 2010-11-10 2015-11-20 H. Lundbeck A/S Radiooznaäśeni ligandi na bazi fenilimidazola
US20140171448A1 (en) * 2011-01-27 2014-06-19 Novartis Ag Use of nicotinic acetylcholine receptor alpha 7 activators
CN103619354A (zh) * 2011-06-30 2014-03-05 东丽株式会社 止痒剂

Also Published As

Publication number Publication date
WO2014111838A1 (en) 2014-07-24
BR112015016995B1 (pt) 2022-02-01
EP2945633A1 (en) 2015-11-25
TW201440766A (zh) 2014-11-01
BR112015016995B8 (pt) 2022-07-26
CA2898080C (en) 2018-01-09
JP6338223B2 (ja) 2018-06-06
CN105263495B (zh) 2019-05-14
JP2016509595A (ja) 2016-03-31
ES2883232T3 (es) 2021-12-07
KR20150105469A (ko) 2015-09-16
BR112015016995A8 (pt) 2018-01-23
CN105263495A (zh) 2016-01-20
EP2945633B1 (en) 2021-06-30
MX2015009155A (es) 2016-03-04
TWI633886B (zh) 2018-09-01
BR112015016995A2 (pt) 2017-07-11
CA2898080A1 (en) 2014-07-24
KR101879920B1 (ko) 2018-07-18

Similar Documents

Publication Publication Date Title
CL2019001224A1 (es) Composiciones de células t con car anti--bcma.
DK3762380T3 (da) Phenylpyrrolidinon-formylpeptid-2-receptoragonister
CL2018000920A1 (es) Conjugados de anticuerpos que comprenden agonistas de receptor similares
CL2017000590A1 (es) Anticuerpos anti-cll-1 e inmunoconjugados
IL258412A (en) Melanocortin-4 receptor (mc4r) agonists for use in treating melanocortin-4 receptor pathway-associated disorders
MX2020014121A (es) Agonistas parciales del receptor de insulina.
MX2015017331A (es) Anticuerpos anti fc similar a receptor 5 (fcrh5).
CR20150482A (es) Anticuerpos e inmunoconjugados anti-b7-h4
MX2016014247A (es) Conjugados de anticuerpo-farmaco anti-proteina tirosina quinasa 7 (anti-ptk7).
MX2017001079A (es) Receptores de antígeno quiméricos de antígeno de maduración de células b (bcma).
ECSP13013022A (es) Agonistas de fgfr1 y sus métodos de uso
CR20160362A (es) Anticuerpos anti-jagged1 y metodos de uso
ZA202507394B (en) Semaglutide in cardiovascular conditions
DK3150578T3 (da) Ny pyrrolidinforbindelse og anvendelse som melanocortin-receptoragonist
MX2015009155A (es) Uso de agonistas del receptor nicotinico de acetilcolina alfa 7.
PL3105186T3 (pl) Urządzenie do rozpraszania u źródła emisji wyziewów gazowych powodujących mdłości
EP3542777A4 (en) MEDICINAL COMPOSITION FOR ROOT CANAL
TR201909125T4 (tr) Yüzey temi̇zlemek i̇çi̇n bi̇r aparat
EP3440051A4 (en) AGROISTS OF NEUROPEPTIDE RECEPTOR (NPSR)
MX379289B (es) Uso de agonistas del receptor nicotinico de acetilcolina alfa 7.
EP3318577A4 (en) ANTIPLEXIN A1 AGONISTANTIKÖRPER
EP3463413A4 (en) INSULIN RECEPTOR PART AGONISTS
EP3551011A4 (en) CART OF MEDICAL INSTRUMENTS
FR3031502B1 (fr) Ensemble de pointage d'un instrument
GB201619637D0 (en) C3a receptor agonists